Published in J Urol on May 20, 2010
Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences? Urology (2012) 1.49
Effective management of lower urinary tract dysfunction in idiopathic Parkinson's disease. Int J Urol (2013) 1.44
Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. Int J Urol (2011) 1.44
Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology (2006) 1.43
Primary small cell bladder carcinoma: a case report and review of the current literature. Tumori (2007) 1.42
Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence? J Urol (2005) 1.13
Ultrasound-guided percutaneous nephrostomy performed by urologists: 10-year experience. Urology (2006) 1.10
The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy. Anticancer Res (2006) 1.07
Percutaneous endourologic procedures in high-risk patients in the lateral decubitus position under regional anesthesia. J Endourol (2009) 1.06
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care (2012) 1.03
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. Crit Rev Oncol Hematol (2008) 0.93
Colon perforation during percutaneous renal surgery: a 10-year experience in a single endourology centre. Urol Res (2012) 0.91
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer. Urology (2011) 0.91
Estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy T3N0M0 locally advanced prostate cancer in an urban Greek population. Asian J Androl (2015) 0.90
Use of external ureteral catheters and internal double J stents in a modified ileal neobladder for continent diversion: a comparative analysis. Urol Int (2005) 0.87
Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa. Shock (2006) 0.85
Biweekly carboplatin/gemcitabine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: report of efficacy, quality of life and geriatric assessment. Oncology (2008) 0.85
An overview of stress urinary incontinence treatment in women. Aging Clin Exp Res (2007) 0.84
Ureteric guidewire damage by Holmium:YAG laser: preliminary results. Urol Res (2009) 0.84
Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia. Urology (2006) 0.84
TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen. BMC Infect Dis (2011) 0.83
The current role of percutaneous chemolysis in the management of urolithiasis: review and results. Urolithiasis (2013) 0.83
Upper urinary tract transitional cell carcinoma. A 10-year experience. Tumori (2008) 0.83
Expression of ERβ and its co-regulators p300 and NCoR in human transitional cell bladder cancer. Urol Int (2011) 0.82
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival. Anticancer Res (2011) 0.82
Local steroid application during nerve-sparing radical retropubic prostatectomy. BJU Int (2005) 0.81
The role of the cell adhesion molecules (integrins/cadherins) in prostate cancer. Int Braz J Urol (2011) 0.81
The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental study. Int J Antimicrob Agents (2008) 0.80
Androgen deprivation therapy and cardiovascular risk. Nephrourol Mon (2012) 0.79
'An interventional urology list' - a novel concept for UK urological services. Ann R Coll Surg Engl (2010) 0.79
Management of JJ stent-related symptoms. Acta Chir Iugosl (2014) 0.79
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group. Anticancer Drugs (2016) 0.79
Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy. J Cancer Res Clin Oncol (2009) 0.79
Laparoscopic transposition of lower-pole crossing vessels in the management of pelvi-ureteric junction obstruction. BJU Int (2008) 0.78
Current status of minimally invasive endoscopic management of ureteric strictures. Ther Adv Urol (2013) 0.77
Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy. World J Urol (2007) 0.76
The novel prostate cancer antigen 3 (PCA3) biomarker. Int Braz J Urol (2010) 0.76
Use of nonsteroidal anti-inflammatory drugs after radical retropubic prostatectomy: a prospective, randomized trial. Urology (2008) 0.76
Bilateral spontaneous retroperitoneal bleeding in a patient on nimesulide: a case report. J Med Case Rep (2011) 0.75
Calcification of the vas deferens and seminal vesicles: a review. Can J Urol (2015) 0.75
Editorial comment on: treatment-seeking, aspects of sexual activity and life satisfaction in men with laser-treated penile carcinoma. Eur Urol (2008) 0.75
Hyoscine N-butylbromide (Buscopan®) in the treatment of acute ureteral colic: what is the evidence? Urol Int (2014) 0.75
The evolution of urolithiasis assessment and management in the new millennium. Panminerva Med (2016) 0.75
Epidemiologic study of urolithiasis in seven countries of South-Eastern Europe: S.E.G.U.R. 1 study. Arch Ital Urol Androl (2017) 0.75
Journal of Endourology and Part B: Videourology Our 2015 Reviewers. J Endourol (2016) 0.75
Panlithiasis of the urinary tract: a case for open lithotomy in the modern era. Urolithiasis (2013) 0.75
Synchronous diagnosis of prostatic adenocarcinoma and sarcoidosis. Int Urol Nephrol (2002) 0.75
In vitro encrustation of a semi-permanent polymer-covered nitinol ureter stent: an artificial urine model. Urolithiasis (2014) 0.75
Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study. Pharmacogenomics (2012) 0.75
Evaluation of findings during re-exploration for obstructive ileus after radical cystectomy and ileal-loop urinary diversion: insight into potential technical improvements. BJU Int (2006) 0.75
Inferior distraction of the kidney to aid upper pole and supracostal punctures during supine percutaneous renal access. Urol J (2012) 0.75
Material fatigue testing of a new intraureteral wire stent (Zebrastent). J Endourol (2008) 0.75
Is it the End for Urologic Pelvic Laparoscopic Surgery? Surg Laparosc Endosc Percutan Tech (2017) 0.75
VIP neobladder (Padovana) reconstruction following radical cystectomy for bladder cancer Complications, functional outcome and quality of life evaluation in 95 cases. Ann Ital Chir (2015) 0.75
Malpingian carcinoma of the urinary bladder: A case series. J Cancer Res Ther (2016) 0.75
The case for probiotics in urology. BJU Int (2007) 0.75
Measurement of PSA density by 3 imaging modalities and its correlation with the PSA density of radical prostatectomy specimen. Urol Oncol (2011) 0.75
In vitro simulation of stent fracture mechanisms in ureteric nitinol wire stents. Urol Res (2008) 0.75